Hjem › Hode- og halskreft › Missouri
Kliniske studier for Hode- og halskreft i Missouri
16 studier for Hode- og halskreft søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site #0114, St Louis
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06788990A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
- Washington University School of Medicine, St Louis
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07848841First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Washington University, St Louis
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06657222Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
- Washington University in St. Louis, St Louis
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT05442957Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
- Washington University School of Medicine, St Louis
RekruttererObservasjonsstudie
Alder 18 til 50 · Kvinner · Oppdatert 2. sep. 2026 · NCT06904365IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. aug. 2026 · NCT06910657First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Saint Luke's Cancer Institute, Kansas City
- Washington University, St Louis
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT05768139Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Saint Louis University, St Louis
RekruttererFase 1/2
Alder 18 til 90 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT06710756Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - SPG, Springfield
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07327489A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Washington University Infusion Center Pharmacy, St Louis
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, St Louis
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 26. mai 2026 · NCT06256588Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- Washington University School of Medicine, St Louis
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 20. feb. 2026 · NCT04354064Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- Washington University in St. Louis, St Louis
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 11. des. 2025 · NCT05793151SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
- University of Missouri, Columbia
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mai 2024 · NCT04444869Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.